86703 studies found for:    United States
Show Display Options
Rank Status Study
1 Not yet recruiting A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Ixekizumab;   Drug: Placebo
2 Not yet recruiting A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions: Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Interventions: Drug: BTD-001;   Drug: Placebo
3 Not yet recruiting AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
Condition: Stage IB-IIIA Non-small Cell Lung Carcinoma, With a Centrally Confirmed, Common Sensitising EGFR Mutations
Interventions: Drug: AZD9291 80 mg/40 mg;   Drug: Placebo AZD9291 80 mg/40 mg
4 Not yet recruiting Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab ITV injection;   Drug: Ranibizumab through RPDS Implant
5 Not yet recruiting A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Condition: Hepatitis C Virus Infection
Interventions: Drug: Sofosbuvir (SOF);   Drug: Ledipasvir/Sofosbuvir (LDV/SOF)
6 Not yet recruiting Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
Conditions: Opioid Use Disorder;   Opioid-related Disorders
Interventions: Drug: SUBOXONE sublingual film;   Drug: high dose RBP-6000;   Drug: low dose RBP-6000
7 Not yet recruiting Reevaluation Of Systemic Early Neuromuscular Blockade
Condition: Acute Respiratory Distress Syndrome
Intervention: Drug: cisastracurium besylate
8 Recruiting Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY)
Condition: Hypogonadism
Intervention: Drug: Testosterone enanthate auto-injector
9 Recruiting A Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
Condition: Chronic Kidney Disease (CKD)
Interventions: Drug: Epoetin Hospira Arm;   Other: Standard of Care Arm
10 Not yet recruiting Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Condition: Peripheral Artery Disease
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
11 Not yet recruiting Study of SRP-4045 and SRP-4053 in DMD Patients
Conditions: Duchenne Muscular Dystrophy;   DMD;   Muscular Dystrophy
Interventions: Drug: SRP-4045;   Drug: SRP-4053;   Drug: Placebo
12 Recruiting Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
13 Not yet recruiting A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Condition: Treatment-resistant Depression
Interventions: Drug: Esketamine;   Drug: Duloxetine;   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
14 Recruiting Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Condition: Fibromyalgia
Interventions: Drug: DS-5565;   Drug: placebo
15 Recruiting Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Type 2
Interventions: Drug: ORMD-0801;   Drug: Placebo Comparator
16 Not yet recruiting A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Condition: Treatment-resistant Depression
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
17 Recruiting Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Conditions: Failed or Difficult Intubation, Sequela;   Intubation; Difficult;   Intubation Complication
Intervention:
18 Recruiting Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)
Condition: Depressive Disorder, Major
Intervention:
19 Recruiting Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Conditions: Breast Adenocarcinoma;   Estrogen Receptor Negative;   HER2/Neu Negative;   Progesterone Receptor Negative;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer;   Triple-Negative Breast Carcinoma
Interventions: Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel
20 Enrolling by invitation Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Condition: Cognition Disorders
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years